99 related articles for article (PubMed ID: 23680591)
1. Simvastatin reduces wasting and improves cardiac function as well as outcome in experimental cancer cachexia.
Palus S; von Haehling S; Flach VC; Tschirner A; Doehner W; Anker SD; Springer J
Int J Cardiol; 2013 Oct; 168(4):3412-8. PubMed ID: 23680591
[TBL] [Abstract][Full Text] [Related]
2. Rosiglitazone reduces body wasting and improves survival in a rat model of cancer cachexia.
Trobec K; Palus S; Tschirner A; von Haehling S; Doehner W; Lainscak M; Anker SD; Springer J
Nutrition; 2014 Sep; 30(9):1069-75. PubMed ID: 24976415
[TBL] [Abstract][Full Text] [Related]
3. Tandospirone reduces wasting and improves cardiac function in experimental cancer cachexia.
Elkina Y; Palus S; Tschirner A; Hartmann K; von Haehling S; Doehner W; Mayer U; Coats AJ; Beadle J; Anker SD; Springer J
Int J Cardiol; 2013 Dec; 170(2):160-6. PubMed ID: 24207070
[TBL] [Abstract][Full Text] [Related]
4. The xanthine oxidase inhibitor oxypurinol reduces cancer cachexia-induced cardiomyopathy.
Springer J; Tschirner A; Hartman K; von Haehling S; Anker SD; Doehner W
Int J Cardiol; 2013 Oct; 168(4):3527-31. PubMed ID: 23751350
[TBL] [Abstract][Full Text] [Related]
5. Megestrol acetate improves cardiac function in a model of cancer cachexia-induced cardiomyopathy by autophagic modulation.
Musolino V; Palus S; Tschirner A; Drescher C; Gliozzi M; Carresi C; Vitale C; Muscoli C; Doehner W; von Haehling S; Anker SD; Mollace V; Springer J
J Cachexia Sarcopenia Muscle; 2016 Dec; 7(5):555-566. PubMed ID: 27239419
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin improves cardiac wasting and outcomes in a rat model of liver cancer cachexia.
Saitoh M; Hatanaka M; Konishi M; Ishida J; Palus S; Ebner N; Döhner W; von Haehling S; Anker SD; Springer J
Int J Cardiol; 2016 Sep; 218():312-317. PubMed ID: 27240157
[TBL] [Abstract][Full Text] [Related]
7. The small molecule ACM-001 improves cardiac function in a rat model of severe cancer cachexia.
Poetsch MS; Palus S; Van Linthout S; von Haehling S; Doehner W; Coats AJS; Anker SD; Springer J
Eur J Heart Fail; 2023 May; 25(5):673-686. PubMed ID: 36999379
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of xanthine oxidase reduces wasting and improves outcome in a rat model of cancer cachexia.
Springer J; Tschirner A; Hartman K; Palus S; Wirth EK; Ruis SB; Möller N; von Haehling S; Argiles JM; Köhrle J; Adams V; Anker SD; Doehner W
Int J Cancer; 2012 Nov; 131(9):2187-96. PubMed ID: 22336965
[TBL] [Abstract][Full Text] [Related]
9. MT-102 prevents tissue wasting and improves survival in a rat model of severe cancer cachexia.
Pötsch MS; Ishida J; Palus S; Tschirner A; von Haehling S; Doehner W; Anker SD; Springer J
J Cachexia Sarcopenia Muscle; 2020 Apr; 11(2):594-605. PubMed ID: 32067370
[TBL] [Abstract][Full Text] [Related]
10. β-hydroxy-β-methylbutyrate (HMB) attenuates muscle and body weight loss in experimental cancer cachexia.
Aversa Z; Bonetto A; Costelli P; Minero VG; Penna F; Baccino FM; Lucia S; Rossi Fanelli F; Muscaritoli M
Int J Oncol; 2011 Mar; 38(3):713-20. PubMed ID: 21184031
[TBL] [Abstract][Full Text] [Related]
11. Cardiac expression of neutrophil gelatinase-associated lipocalin in a model of cancer cachexia-induced cardiomyopathy.
Musolino V; Palus S; Latouche C; Gliozzi M; Bosco F; Scarano F; Nucera S; Carresi C; Scicchitano M; von Haehling S; Jaisser F; Hasenfuss G; Anker SD; Mollace V; Springer J
ESC Heart Fail; 2019 Feb; 6(1):89-97. PubMed ID: 30367561
[TBL] [Abstract][Full Text] [Related]
12. Febuxostat improves outcome in a rat model of cancer cachexia.
Konishi M; Pelgrim L; Tschirner A; Baumgarten A; von Haehling S; Palus S; Doehner W; Anker SD; Springer J
J Cachexia Sarcopenia Muscle; 2015 Jun; 6(2):174-80. PubMed ID: 26136193
[TBL] [Abstract][Full Text] [Related]
13. No effects of human ghrelin on cardiac function despite profound effects on body composition in a rat model of heart failure.
Akashi YJ; Palus S; Datta R; Halem H; Taylor JE; Thoene-Reineke C; Dong J; Thum T; Culler MD; Anker SD; Springer J
Int J Cardiol; 2009 Nov; 137(3):267-75. PubMed ID: 18723230
[TBL] [Abstract][Full Text] [Related]
14. Formoterol fumarate and roxithromycin effects on muscle mass in an animal model of cancer cachexia.
Kenley RA; Denissenko MF; Mullin RJ; Story J; Ekblom J
Oncol Rep; 2008 May; 19(5):1113-21. PubMed ID: 18425366
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol does not ameliorate muscle wasting in different types of cancer cachexia models.
Busquets S; Fuster G; Ametller E; Olivan M; Figueras M; Costelli P; Carbó N; Argilés JM; López-Soriano FJ
Clin Nutr; 2007 Apr; 26(2):239-44. PubMed ID: 17261345
[TBL] [Abstract][Full Text] [Related]
16. The atypical β-blocker S-oxprenolol reduces cachexia and improves survival in a rat cancer cachexia model.
Yuan L; Springer J; Palus S; Busquets S; Jové Q; Alves de Lima Junior E; Anker MS; von Haehling S; Álvarez Ladrón N; Millman O; Oosterlee A; Szymczyk A; López-Soriano FJ; Anker SD; Coats AJS; Argiles JM
J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):653-660. PubMed ID: 36346141
[TBL] [Abstract][Full Text] [Related]
17. IGF-1 treatment reduces weight loss and improves outcome in a rat model of cancer cachexia.
Schmidt K; von Haehling S; Doehner W; Palus S; Anker SD; Springer J
J Cachexia Sarcopenia Muscle; 2011 Jun; 2(2):105-109. PubMed ID: 21766056
[TBL] [Abstract][Full Text] [Related]
18. Effects of simvastatin administration in an experimental model of cancer cachexia.
Muscaritoli M; Costelli P; Bossola M; Grieco G; Bonelli G; Bellantone R; Doglietto GB; Rossi-Fanelli F; Baccino FM
Nutrition; 2003; 19(11-12):936-9. PubMed ID: 14624942
[TBL] [Abstract][Full Text] [Related]
19. The influence of age and sex on disease development in a novel animal model of cardiac cachexia.
Palus S; Akashi Y; von Haehling S; Anker SD; Springer J
Int J Cardiol; 2009 Apr; 133(3):388-93. PubMed ID: 19246111
[TBL] [Abstract][Full Text] [Related]
20. Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure.
Mulder P; Barbier S; Chagraoui A; Richard V; Henry JP; Lallemand F; Renet S; Lerebours G; Mahlberg-Gaudin F; Thuillez C
Circulation; 2004 Apr; 109(13):1674-9. PubMed ID: 14981003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
